View ICR - OIRA Conclusion



0910-0701 202006-0910-014
Historical Active 201804-0910-004
HHS/FDA CDER
Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic: Agency Guidance
No material or nonsubstantive change to a currently approved collection   No
Regular
Approved without change 06/26/2020
06/24/2020
  Inventory as of this Action Requested Previously Approved
05/31/2021 05/31/2021 05/31/2021
6,500 0 6,500
262,000 0 262,000
0 0 0